Pharmaceuticals

US warns drugmaker Emcure for ‘fudging’ test results

17 Mar 2016

Biocon inks co-development and marketing pact with Mexican co for rh-insulin

17 Mar 2016

British respiratory drug maker Vectura to buy Skyepharma for $621 mn

17 Mar 2016

Jan Aushadhi makes available 88 essential drugs and other medical products

16 Mar 2016

P&G follows Pfizer, Abbot, ends sale of cold remedy

15 Mar 2016

Valeant Pharmaceuticals cuts revenue forecast by 12%

15 Mar 2016

India bans Pfizer, Abbot cough syrups; shares tank

14 Mar 2016

The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling

Charterhouse to sell Italian generic drugs firm Doc Generici to CVC Capital

12 Mar 2016

European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions

11 Mar 2016

The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland